68 filings
Page 3 of 4
8-K
vo1huv1805lbx6
10 Dec 15
Cynapsus Therapeutics Announces Successful Completion of Bioavailability and Pharmacokinetic Study and Provides Update on European Clinical Plans
12:00am
8-K
f1sra gnqier3mer
12 Nov 15
Cynapsus Therapeutics Reports Third Quarter 2015 Financial Results and Recent Developments
12:00am
8-K
2x9s 2dm3b
2 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
ajz4hto3j0b
4 Sep 15
Entry into a Material Definitive Agreement
12:00am
8-K
v9mua2
14 Aug 15
Cynapsus Therapeutics Reports Second Quarter 2015 Financial Results and Recent Developments
12:00am
10-Q
pd6wcsrm2
14 Aug 15
Quarterly report
12:00am
S-8
9y0nun uiq
29 Jul 15
Registration of securities for employees
12:00am
8-K
w0gp2gn5djyaq
23 Jun 15
Cynapsus Therapeutics Inc. Closes US$72.5 Million Public Offering of Common Shares in the United States
12:00am
SUPPL
yftw55 h5ysump
18 Jun 15
Supplemental materials (foreign)
12:00am
FWP
na497ey ewba
18 Jun 15
Free writing prospectus
12:00am
8-K
t5vo4j740n2w3cn2u4p
18 Jun 15
Cynapsus Therapeutics Inc. Announces Pricing of US$63.0 Million Public Offering of
12:00am
F-10/A
f7vm 7xgsw6ny
17 Jun 15
Registration of securities (Canada) (amended)
12:00am
EFFECT
9ldr 86af
17 Jun 15
Notice of effectiveness
12:00am
8-A12B
cjlwtp11
12 Jun 15
Registration of securities on exchange
12:00am
F-10/A
zomzxh9n8whxj etn4k
9 Jun 15
Registration of securities (Canada) (amended)
12:00am
F-10
62urcf7mh4 nnrzq6
15 May 15
Registration of securities (Canada)
12:00am
F-X
ufvg2h
15 May 15
Appointment of agent for service of process by issuers registering securities
12:00am
D
aulwilem cy1v3
14 Apr 15
$16.75M in equity, sold $16.75M, 14 investors
12:00am
D
c6dpgt
21 Apr 14
$42.92M in equity / options / securities to be acquired, sold $14.55M, 19 investors
12:00am